People think splitting or spacing out their dose might help stretch their supply, Defnet says
It has gone through a development programme, including a cardiovascular outcomes trial, which have shown beneficial effects, but has not yet been approved [22]
You've protected it this far
Standards of Care in DiabetesGLP-1 Therapies
Desire an FDA-approved, well-tolerated non-surgical weight loss treatment Who Should Not Use GLP-1 Medications These medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)
But knowing which variants a person carries, he says, can be quite informative for individuals who are considering these medications